2/20/24 Strategy Session Highlights: Injectable Weight Loss Medications

In this weeks episode, we'll explore how injectables like Zepbound/Mounjaro (tirzepatide) and Wegovy/Ozempic (semaglutide) are reshaping the landscape of healthcare. These medications work by increasing hormones that improve blood sugar processing, suppress hunger in the brain and slowing gut emptying, leading to prolonged feelings of fullness and less fat storage. Additionally, Zepbound/Mounjaro (tirzepatide) offer a dual therapy advantage by incorporating another hormone called GIP, enhancing their effectiveness even further. But beyond the science, we'll also delve into the critical distinction between personal health insight and external opinions. Not every medical professional fully understands the benefits and risks of these medications, especially in the context of treating obesity. Throughout this episode, we'll cover: How injectables work and the hormone therapy advantage. The wide-ranging benefits they offer, from weight loss to diabetes control, insightful studies, safety considerations, potential side effects, costs, and more.